Purpose : The study was undertaken to test whether human telomerase reverse transcriptase (hTERT) transcripts in an individual blastomere could be used as an indicator for embryo development. Methods : Group A consisted of day 3 normal cleaving embryos at 4-to 8-cell stage, which were surplus and not allocated for uterine transfer. Group B consisted of arrested or fragmented embryos at the same stage, which were considered to be compromised. After blastomere dissociation, RNA purification, reverse transcription, and hTERT PCR amplification, the amplified product was separated by 3% gel electrophoresis. Results : Eighty-six (90.5%) of the 95 intact blastomeres in group A and 78 (70.9%) of the 110 blastomeres in group B demonstrated hTERT mRNA expression. The difference was statistically significant (P < 0.05, chi-square). Eight (38.1%) of the 21 embryos in group A and 22 (62.9%) of the 35 embryos in group B had at least one blastomere that did not express hTERT mRNA under this procedure. The difference was not significant (P > 0.05, chi-square). Conclusions : General hTERT mRNA transcripts can be detected in most of the individual blastomeres but cannot be used as an indicator for early embryo development. Further investigations are necessary to elucidate its clinical application.
INTRODUCTION
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the DNA repeats are highly conserved TTAGGG nucleotide segments (1) . Its shortening correlates with the number of cell divisions. When the telomere length reaches a certain limit, it will signal the cell to undergo replicate senescence, under which the cells stop cell division, become resistant to apoptosis, and alter their normal functions (4) . Telomerase is a ribonucleoprotein (5) . Its RNA subunit acts as a template for the synthesis of telomeric DNA, whereas its protein component catalyzes this process to make up for the inability of polymerase to replicate linear DNA through conventional replication (6) . It has been hypothesized that telomerase activity is necessary for cellular immortalization (7) . Most of the reports regarding telomerase activity were focused on the research of cancer biology or cell aging (8, 9) . In humans, telomerase activity is only found in germ cells and embryos, immortalized cell lines, and most tumor cells; it is not found in cells of most somatic tissues (7) . Lack of telomerase activity in somatic cells, and the finite length of telomeric DNA would limit the number of cell divisions. Most tumor and immortal cells have telomerase turned on as a mechanism to counteract telomere loss, thus enabling them to divide infinitely (7, 10) . Consistent with the hypothesis, telomerase activity has been detected in extracts of human ovaries and testes (11, 12) . Although other reports showed that telomerase activity was relatively high in blastocyst-stage embryos (13, 14) , very little is known about telomerase activity and its components in human single blastomeres possibly because of difficulties in obtaining sufficient samples for analysis. But analysis of a single blastomere is more helpful in our clinical practice of human in vitro fertilization (IVF) system. Through embryo biopsy and analysis of a blastomere, it is now possible for us to evaluate an embryo prior to uterine transfer (15) .
The constituents and action of the telomerase complex have recently been further identified. Human telomerase catalytic subunit (hTCS), or human telomerase reverse transcriptase (hTERT), a recently cloned enzyme, has been found (16) . Its expression at the mRNA level has been reported to be strongly associated with enzyme activity and concomitant immortalization (17, 18) . Its introduction into normal human epithelial cells and fibroblasts was sufficient to reconstitute telomerase activity, arrest telomere shortening, and extend the life span in vitro (19) .
On the basis of the importance of telomerase for cellular meiosis and mitosis, a similar process as early human embryo development, we designed this study for the assessment of hTERT mRNA in individual blastomeres. With the recent cloning of the hTERT gene, it is now possible to detect telomerase-positive cells by a more sensitive reverse transcription-polymerase chain reaction (RT-PCR), rather than the telomerase enzymatic assay called telomeric repeat amplification protocol (TRAP) (7, 11) , which requires more well-preserved fresh tissue that is rarely available in a routine clinical setting. The objective of this study was to demonstrate its mRNA expression in single blastomeres first, so that we can better understand embryo physiology, use it as a predictor for embryonic health and development, and select a best embryo for uterine transfer.
MATERIALS AND METHODS

Embryos Collection
Oocytes were obtained from patients undergoing assisted reproductive techniques (ART). Ovarian stimulation for ART was administered with recombinant human follicular stimulating hormone (r-FSH; Gonal-F; Serono, Zug, Switzerland) and/or human menopausal gonadotropin (HMG; Pergonal; Serono, Zug, Switzerland) after standard pituitary downregulation with gonadotropin-releasing hormone agonist (GnRHa; Lupron; Tap Pharmaceuticals, Deerfield, IL) until at least two follicles had attained a mean diameter of 17 mm. Oocytes retrieval was performed 34-36 h after 10000 IU of human chorionic gonadotropin (hCG; Profasi; Serono, Zug, Switzerland) was administered. Fertilization was performed 4-6 h after oocyte retrieval with either conventional insemination or intracytoplasmic sperm injection (ICSI) as appropriate. The oocytes were checked for fertilization by the presence and number of pronuclei (PN). These embryos were cultured for 72 h after retrieval. Under patients' informed consent, the experiment was divided into two groups. Group A consisted of normal cleaving embryos at 4-to 8-cell stage, which were surplus and not allocated for uterine transfer. Group B consisted of arrested or fragmented embryos at the same stage, which were considered to be compromised.
Blastomeres Collection
The embryos were placed for 2 min in acid Tyrode solution for zona removal. Afterward, the zona-free embryos were placed for 3 min in calciumand magnesium-free medium for dissociation of blastomeres. After repeated pipetting, individual blastomeres with a distinctive nucleus were separated. All blastomeres were washed thoroughly in sterile phosphate-buffered saline (PBS) in plastic dishes and then transferred to 0.2-mL tubes in as small a volume as possible. A 50 µL sample of denaturing solution (Fast-Run RT-PCR Kit; HT Biotechnology, Cambridge, UK) was added immediately after transfer and the tube was briefly vortexed. Some samples were frozen and stored at −70
• C prior to RNA purification.
RNA Purification
Previously frozen samples were thawed and RNA purification was performed using the Fast-Run RT-PCR Kit (HT Biotechnology, Cambridge, UK) according to the manufacturer's protocol. Copies (10 6 ) of the human epidermoid-carcinoma cells SiHa mRNA (ATCC, Rockville, MD, USA) were added as a positive control. The SiHa cell line was established from fragments of a primary tissue sample of an undifferentiated squamous carcinoma of the cervix.
Reverse Transcription
The reverse transcription reaction was performed by incubating the mRNA with 11.5 µL master mix solution consisting of 4 µL of 25 mM MgCl 2 , 2.0 µL 10X PCR buffer (Perkin Elmer Inc, Foster City, CA, USA), 4.0 µL 100 mM dNTP, 1.0 µL RNase inhibitor (Perkin Elmer Inc), 0.5 µL 50 IU/µL Maloney murine leukaemia virus (MMLV) reverse transcriptase (Perkin Elmer Inc), and 0.5 µL random hexamers. The mRNA was reverse transcribed at 37
• C for 1 h, followed by inactivation of the MMLV enzyme by incubation at 95
• C for 5 min (12).
hTERT PCR Amplification
An aliquot of cDNA was used as a template for PCR amplification using a 9600 Perkin Elmer system in a total reaction volume of 50 µL containing 1.5 mmol/l MgCl 2 , 1 mmol/l dNTP mix, 1X Q Solution, 0.5 µmol/l of each gene-specific primer, and 1.25 IU Taq DNA polymerase (Quiagen Inc, Chatsworth, CA, USA). The following amplification profile was applied: 1 cycle, 94
• C for 2 min; 35 cycle of 94 • C for 2 min, 58
• C for 1 min, 72
• C for 1 min; 1 cycle, 94
• C for 7 min; hold at 4
• C. Primer pair LT5 (5 -CGGAAGA-GTGTCTGGAGCAA-3 ) and LT6 (5 -GGATGAA- GCGGAGTCTGGA-3 ) were used as gene-specific PCR primers to amplify hTERT mRNA (16) . The amplification would result in a PCR product size of 145 bp in all hTERT mRNA transcripts (general transcripts) (20) . To obtain better resolution, PCR products were separated by 3% gel electrophoresis using NuSieve GTG agarose (FMG Inc., Rockland, ME, USA), stained with ethidium bromide and visualized under UV illumination.
RESULTS
Analysis of Each Blastomere of Entire Normal-Cleaving Embryos
Blastomeres of normal-cleaving embryos were separated and assayed individually to provide information on the variability of hTERT mRNA from one blastomere to the next within an entire embryo. Twenty-one embryos were donated from 17 patients. During isolation, 17/112 (15.2%) of the individual blastomeres lysed. Intact blastomeres were analysed for the mRNA expression of hTERT. Of the 95 intact blastomeres evaluated, 86 (90.5%) demonstrated presence of hTERT mRNA by the expression of 145 bp amplified product (Fig. 1) . Eight (38.1%) of the 21 embryos had at least one blastomere that did not express presence of hTERT mRNA under this procedure.
Analysis of Each Blastomere of Entire Compromised Embryos
Blastomeres of compromised embryos were separated and assayed individually as those from normal-cleaving embryos. Thirty-five embryos were donated from 22 patients. During isolation 29/139 (20.9%) of the individual blastomeres lysed. Of the 110 intact blastomeres evaluated, 78 (70.9%) demonstrated presence of hTERT mRNA. Twenty-two (62.9%) of the 35 embryos had at least one cell that did not express presence of hTERT mRNA.
Telomerase Activity in Human Blastomeres as a Predictor for Embryo Viability and Development
The difference (90.5% vs. 70.9%) in the expression of the amplified product from hTERT mRNA in the individual blastmeres from normal-cleaving and compromised embryos was significant in statistics (P < 0.05, chi-square). While the difference (38.1% vs. 62.9%) in the embryos that had at least one cell that did not express presence of hTERT mRNA was not significant in statistics (P > 0.05, chi-square).
DISCUSSION
Despite the fact that telomerase activity has been studied thoroughly in cancer behavior and cell aging (8, 9) , very few data in human oocytes and embryos have been published (12) (13) (14) 21) . Wright et al. (13) analyzed single mature oocytes retrieved from ovarian tissue of patients undergoing hysterectomy and adult sperm samples. They reported that both mature gametes lacked telomerase activity. However, fertilized human embryos were thawed and cultured to the blastocyst stage, analyzed individually, and found to express very high levels of telomerase activity in the same study. With the increased sensitivity of the assay employed, many other studies have found measurable, albeit low, levels of the telomerase activity in the mature oocyte (14, 22, 23) .
To enhance the implantation and pregnancy rate in an IVF treatment, the embryos should be carefully evaluated in order to select those with the highest implantation potential. However, the limitations of evaluating embryos based on morphological criteria alone were well recognized (24, 25) . Except when the embryos are clearly fragmenting, correlations between gross morphology and implantation capability are weak and inaccurate. Many centers have worked on more objective criteria for judging embryo viability and implantation potential (26) (27) (28) (29) . At this moment, nevertheless, it is difficult to incorporate these selection procedures into an IVF practice. Morphological assessment, although unsatisfactory, is quick, noninvasive, and easy to carry out in general practice.
A common belief is that telomerase activity depends on the presence of hTERT transcripts (20, 30) . Human oocytes and embryos have been evaluated for alternative splice variants of the telomerase catalytic subunit (hTCS, or hTERT) (12) . All of them express hTERT mRNA, but expression varies dramatically. Nevertheless, a relationship between poor quality embryo and an increase in alternative splicing variants of hTERT mRNA was found. They suggested that the presence of alternately spliced mRNA variants in human preimplantation embryos may suggest a lack of telomerase activity and thus chromosomes associated with shortened telomeres. However, telomerase activity was not compared between oocytes and embryos in their study. Wright et al. studied samples that were discarded from IVF cycles (21) . Telomerase activity was detected in all developmental stages from immature oocytes through blastocyst stage embryos. Moreover, thawed zygotes were cultured to day 3, biopsied by removing 1-2 cells, and the biopsied embryos were cultured to blastocyst stage. They found that there was no difference in telomerase activity between cells biopsied from embryos that reached the blastocyst stage and cells from those that arrested in growth. However, their samples were derived from thawed zygotes, which might be different from fresh ones in cell physiology.
With the aim to determine the possibility of using hTERT mRNA expression of single biopsied blastomeres, we conducted this study in individual human blastomeres from fresh embryos not allocated for uterine transfer. Through embryo biopsy and RT-PCR system, the expression of hTERT mRNA in individual blastomeres was determined first. Accordingly we could be able to evaluate embryo viability and predict future embryo development. In our study, two different regions of hTERT mRNA were amplified in parallel: primers LT 5 (hTERT 1784), and LT 6 (hTERT 1910) amplify a 145-bp segment present in all hTERT mRNA transcripts (general transcripts) (16, 20) . The result demonstrated that the difference in the expression of hTERT mRNA in the individual blastmeres from normal-cleaving and compromised embryos was significant in statistics. Our results are different from Brenner's study (12) in the aspects that we performed the study in single blastomeres instead of a whole embryo, and that all transcripts (general hTERT transcripts) were detected instead of alternately spliced variants. A full-length hTERT transcript accomplished by using primers that span the putative splice site or a quantitative assessment of hTERT expression levels by real-time PCR, which is nonetheless delicate and sometimes impossible in a clinical setting, might be required for further verification. We did not try to employ a quantitative measure in this study partly because we would like to make the procedures more timesaving and less complicated in order to be applied clinically, and partly because previous report from blastomeres of disaggregated embryos showed a significant variability in telomerase levels within blastomeres in an embryo (21) . Additionally, considering the embryos from normalcleaving and compromised condition that had at least one blastomeres which did not express presence of hTERT mRNA, the difference was not significant in the present study. This may further explain the fact delineated by Brenner et al. (12) that all human preimplantation embryos express hTERT mRNA.
Although our results showed that the difference in the detection of general hTERT mRNA transcripts in the individual blastmeres from normal-cleaving and compromised embryos was significant in statistics, we could not predict embryo developmental potential simply from our results, because blastomeres from compromised embryos also showed a relatively high incidence of hTERT mRNA expression (70.6%). Besides the possibility of false negative results in our study, such a high incidence of mRNA expression in individual blastomeres would make it impossible to differentiate between good and bad embryos for uterine transfer. Furthermore, the result also implicates that telomerase and its components may play only a partial role in embryo development. In fact, not only telomerase, but also many other diverse factors, including nutrition, embryo metabolism, culture/coculture system, gamete formation, embryonic genome activation, and imprinting, are known to affect embryo viability and development (31) . More comprehensive and informative assessments of an embryo are needed to explore and clarify the behavior of early human embryos in vitro.
In summary, our results demonstrate that general hTERT mRNA transcripts can be detected in most of the individual blastomeres but cannot be used as an indicator for early embryo development. The conclusion is consistent with the report by Wright et al. (21) that there was no difference in telomerase activity between cells biopsied from embryos that reached the blastocyst stage and cells from those that arrested in growth. Further investigations are necessary to elucidate its biological significance and clinical application.
